Unchained Labs Lands $25M

Pleasanton-based Unchained Labs, a developer of life sciences tools, said today that it has raised $25M in a Series A funding round. The company said the funding came from Novo Ventures, Canaan Partners and TPG Biotech. In addition to the funding, Unchained Labs said it has acquired Optim, a developer of a multiplex protein stability platform for biologics. Financial terms of the buy were not announced. Unchained Labs is led by Tim Harkness. More information »